Ajooni Biotech Limited has informed the Exchange regarding Change in Auditors of the company.
AJOONI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ajooni Biotech's Board, at its meeting on August 29, 2025, approved the appointment of M/s. SDK & Associates—a peer-reviewed firm of Practicing Company Secretaries—as the company's new Secretarial Auditor for a five-year term starting FY 2025-26 through FY 2029-30. The appointment is subject to shareholder approval at the 15th Annual General Meeting scheduled for September 29, 2025. The change is being made to comply with Section 204 of the Companies Act, 2013 and SEBI LODR Regulation 24(A). SDK & Associates, founded in 2021 and led by Proprietor Shubham (Membership No. 65153), has provided its formal consent and confirmed eligibility. Importantly, this pertains to the Secretarial Auditor, not the statutory/financial auditor.
This is a routine regulatory compliance filing—appointment of a Secretarial Auditor is mandatory under the Companies Act. No negative governance signal or mid-term auditor resignation is involved, so it is unlikely to have any material impact on the stock price.